1-20 of 26
Authors: Steven G Reed
Journal Article
Computationally Designed Bispecific MD2/CD14 Binding Peptides Show TLR4 Agonist Activity Get access
The Journal of Immunology, Volume 201, Issue 11, December 2018, Pages 3383–3391, https://doi.org/10.4049/jimmunol.1800380
Published: 01 December 2018
Journal Article
Use of GLA-nanoalum as an effective adjuvant for a therapeutic ID93 TB vaccine Get access
The Journal of Immunology, Volume 200, Issue Supplement_1, May 2018, Page 180.21, https://doi.org/10.4049/jimmunol.200.Supp.180.21
Published: 01 May 2018
Journal Article
Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization Get access
The Journal of Immunology, Volume 197, Issue 11, December 2016, Pages 4413–4424, https://doi.org/10.4049/jimmunol.1600282
Published: 01 December 2016
Journal Article
IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants Get access
The Journal of Immunology, Volume 197, Issue 11, December 2016, Pages 4351–4359, https://doi.org/10.4049/jimmunol.1600993
Published: 01 December 2016
Journal Article
Mechanisms of activity of the combination TLR4 agonist and emulsion adjuvant GLA-SE Get access
The Journal of Immunology, Volume 196, Issue 1_Supplement, May 2016, Page 75.2, https://doi.org/10.4049/jimmunol.196.Supp.75.2
Published: 01 May 2016
Journal Article
The TLR4 agonist vaccine adjuvant, GLA-SE, requires canonical and atypical mechanisms of action for TH1 induction Get access
The Journal of Immunology, Volume 196, Issue 1_Supplement, May 2016, Page 75.7, https://doi.org/10.4049/jimmunol.196.Supp.75.7
Published: 01 May 2016
Journal Article
Increased protection and decreased lung immunopathology induced by the ID93/GLA-SE vaccine candidate following infection with Mycobacterium tuberculosis HN878. Get access
The Journal of Immunology, Volume 196, Issue 1_Supplement, May 2016, Page 76.20, https://doi.org/10.4049/jimmunol.196.Supp.76.20
Published: 01 May 2016
Journal Article
Immune Subdominant Antigens as Vaccine Candidates against Mycobacterium tuberculosis Get access
The Journal of Immunology, Volume 193, Issue 6, September 2014, Pages 2911–2918, https://doi.org/10.4049/jimmunol.1401103
Published: 15 September 2014
Journal Article
Protection against Tuberculosis with Homologous or Heterologous Protein/Vector Vaccine Approaches Is Not Dependent on CD8+ T Cells Get access
The Journal of Immunology, Volume 191, Issue 5, September 2013, Pages 2514–2525, https://doi.org/10.4049/jimmunol.1301161
Published: 01 September 2013
Journal Article
The Importance of Adjuvant Formulation in the Development of a Tuberculosis Vaccine Get access
The Journal of Immunology, Volume 188, Issue 5, March 2012, Pages 2189–2197, https://doi.org/10.4049/jimmunol.1102696
Published: 01 March 2012
Journal Article
Applying TLR Synergy in Immunotherapy: Implications in Cutaneous Leishmaniasis Get access
The Journal of Immunology, Volume 185, Issue 3, August 2010, Pages 1701–1710, https://doi.org/10.4049/jimmunol.1000238
Published: 01 August 2010
Journal Article
Cross-protective humoral and cellular immune responses to A/H3N2 drifted influenza viruses following immunization with Fluzone® with a synthetic TLR4 agonist formulation (45.11) Get access
The Journal of Immunology, Volume 182, Issue Supplement_1, April 2009, Page 45.11, https://doi.org/10.4049/jimmunol.182.Supp.45.11
Published: 01 April 2009
Journal Article
Immunoglobulin G and M Detection for Leprosy Diagnosis (129.18) Get access
The Journal of Immunology, Volume 182, Issue Supplement_1, April 2009, Page 129.18, https://doi.org/10.4049/jimmunol.182.Supp.129.18
Published: 01 April 2009
Journal Article
Enhanced T helper 1 (Th1) responses with Fluzone® adjuvanted with a synthetic TLR4 agonist in an emulsion (45.15) Get access
The Journal of Immunology, Volume 182, Issue Supplement_1, April 2009, Page 45.15, https://doi.org/10.4049/jimmunol.182.Supp.45.15
Published: 01 April 2009
Journal Article
The role of IL-17 in the protective immune response to Mycobacterium tuberculosis (44.18) Get access
The Journal of Immunology, Volume 182, Issue Supplement_1, April 2009, Page 44.18, https://doi.org/10.4049/jimmunol.182.Supp.44.18
Published: 01 April 2009
Journal Article
Identification of Human T Cell Antigens for the Development of Vaccines against Mycobacterium tuberculosis Get access
The Journal of Immunology, Volume 181, Issue 11, December 2008, Pages 7948–7957, https://doi.org/10.4049/jimmunol.181.11.7948
Published: 01 December 2008
Journal Article
Cloning of the Gene Encoding a Protective Mycobacterium tuberculosis Secreted Protein Detected In Vivo during the Initial Phases of the Infectious Process Get access
The Journal of Immunology, Volume 175, Issue 8, October 2005, Pages 5298–5305, https://doi.org/10.4049/jimmunol.175.8.5298
Published: 15 October 2005
Journal Article
Differential Immune Responses and Protective Efficacy Induced by Components of a Tuberculosis Polyprotein Vaccine, Mtb72F, Delivered as Naked DNA or Recombinant Protein Get access
The Journal of Immunology, Volume 172, Issue 12, June 2004, Pages 7618–7628, https://doi.org/10.4049/jimmunol.172.12.7618
Published: 15 June 2004
Journal Article
Vaccination with the T Cell Antigen Mtb 8.4 Protects Against Challenge with Mycobacterium tuberculosis Get access
The Journal of Immunology, Volume 166, Issue 10, May 2001, Pages 6227–6235, https://doi.org/10.4049/jimmunol.166.10.6227
Published: 15 May 2001
Journal Article
Classically Restricted Human CD8+ T Lymphocytes Derived from Mycobacterium tuberculosis-Infected Cells: Definition of Antigenic Specificity Get access
The Journal of Immunology, Volume 166, Issue 1, January 2001, Pages 439–446, https://doi.org/10.4049/jimmunol.166.1.439
Published: 01 January 2001
